Focused LED red-light treatment for adults with nearsightedness
Official title: Safety and Efficacy of Focused LED-Based Repeated Low-Level Red-Light Therapy in Myopic Adults: A Single-Arm Pilot Study
Run by The Hong Kong Polytechnic University · NCT07369804 · Data updated 2026-11-12
This pilot tests whether short, home-based red LED light sessions can thicken the choroid and boost choroidal blood flow in adults ages 18–50 with mild to moderate myopia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 14 (estimated) |
| Sponsor | The Hong Kong Polytechnic University Academic / other |
| Locations | 1 site (Hong Kong, Hong Kong) |
| Status | Recruiting |
| Started | October 8, 2025 |
| Main results expected | July 31, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | January 27, 2026 |
| Trial ID | NCT07369804 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–50 years old with mild to moderate myopia (SE −0.50 to −6.00 D), astigmatism ≤1.50 D, best-corrected visual acuity better than 20/20, and no recent myopia-control treatments or ocular surgery.
✕Probably not a fit
Patients with high myopia beyond −6.00 D, significant ocular disease, prior ocular surgery, binocular vision disorders like strabismus, recent myopia-control interventions, or an afterimage time >5 minutes are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-arm, open-label pilot will enroll 14 myopic adults (18–50 years) with spherical equivalent refractions of −0.50 to −6.00 D to receive focused LED-based repeated low-level red-light (fLED-RLRL) therapy. Participants will use a home device (650 ± 10 nm, 0.20 mW) twice daily for 3 minutes per session, five days per week for 28 days while wearing single-vision spectacles. The primary outcomes are changes in choroidal thickness and choroidal blood flow, and secondary outcomes focus on safety and tolerability. Key exclusions include recent myopia-control treatments within 6 months, prior ocular surgery, strabismus, and other ocular or systemic abnormalities.
Why it matters
Potential benefit: If successful, the therapy could increase choroidal thickness and blood flow and potentially support a noninvasive home-based approach to reduce myopia-related eye changes.
How similar studies have gone: Similar low-level red-light protocols have produced short-term choroidal thickening and slowed progression in pediatric studies, but adult data are limited and this adult protocol is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-50 years. 2. SE refractions between -0.50 and -6.00 diopters (D) 3. Astigmatism of 1.50 D or less. 4. Best corrected monocular visual acuity better than 20/20 (Snellen equivalent). 5. Willingness to provide written informed consent and comply with the treatment protocol. Exclusion Criteria: 1. Strabismus or binocular vision abnormalities in either eye. 2. Ocular abnormalities in either eye or other systemic abnormalities. 3. Previous or current use of myopia control interventions (e.g., orthokeratology, low-dose atropine, pirenzepine) within the past 6 months. 4. History of ocular surgeries (e.g., cataract surgery and LASIK/SMILE). 5. Afterimage time \> 5 minutes (contraindications to RLRL therapy).
Where it's running
-
The Hong Kong Polytechnic University
Hong Kong, Hong Kong, China Recruiting
Study contacts
- Study coordinator: Mingguang He
- Email: mingguang.he@polyu.edu.hk
- Phone: 85234002795
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
-
Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia
This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.
-
Seeing clearly in low light after Ray-Tracing guided LASIK
A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.